Tina Cheng, Daniel Y Heng, Douglas Stewart. Show Affiliations »
Abstract
Entities: Disease
Mesh: See more » Follow-Up StudiesHumansMaleNeoplasm MetastasisNeoplasm StagingProstatic Neoplasms/mortalityProstatic Neoplasms/pathologyProstatic Neoplasms/radiotherapyRadiotherapy, AdjuvantRandomized Controlled Trials as TopicRisk FactorsSurvival RateTime Factors
Year: 2009 PMID: 19766252 DOI: 10.1016/j.juro.2009.07.053
Source DB: PubMed Journal: J Urol ISSN: 0022-5347 Impact factor: 7.450